Breaking News

Financial Report: Cambrex 3Q11

Sales were up 18%

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Cambrex 3Q11 3Q Revenues: $59.2 million (+24%) 3Q Earnings: $2.8 million (loss of $1.5 million 3Q10) YTD Revenues: $188.1 million (+16%) YTD Earnings: $10.2 million (+104%) Comments: Sales were up 18% in the quarter, excluding a 7% favorable impact of foreign exchange. Growth was primarily due to higher volumes of an API for a customer who experienced a disruption in its supply chain for most of 2010. Increases were partially offset by lower pricing across several product categories, lower ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters